recently approved targeted therapy for fourth-line gist
Published 4 years ago • 179 plays • Length 9:03Download video MP4
Download video MP3
Similar videos
-
3:05
safety and efficacy of a newer tki for fourth-line gist
-
1:37
progressing gastrointestinal stromal tumor
-
7:16
standard treatment options for metastatic gist
-
4:25
the role of adjuvant therapy for gist
-
2:38
third-line therapy for gist
-
3:15
advanced gist: the impact of newly approved agents
-
3:31
gist: treatment considerations
-
1:28:27
a joint effort to improve care in tenosynovial giant cell tumors: targeted therapies in practice
-
5:57
gist: third-line treatment considerations
-
4:00
treatment options in gastrointestinal stromal tumors
-
4:13
third-line therapy for metastatic gist
-
5:49
utilizing newer tkis to treat gist
-
7:05
gist: treating with ripretinib
-
1:21
weinberg describes the available options for patients with gist
-
5:13
gist: future treatment landscape
-
3:06
use of targeted therapy in gist mutations
-
5:00
gist mutations: treatment decision factors
-
1:11:39
targeted therapy for gists
-
9:16
mastering gist treatment: imatinib and other targeted therapy for gastrointestinal stromal tumors